1. Search Result
Search Result
Results for "

MYT1

" in MedChemExpress (MCE) Product Catalog:

12

Inhibitors & Agonists

2

Recombinant Proteins

2

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-145664

    Wee1 Cancer
    Myt1-IN-1 is a potent membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50 of <10 nM. Myt1-IN-1 has anticancer effects (WO2021195782A1; compound 132) [1].
    Myt1-IN-1
  • HY-145666

    Wee1 Cancer
    Myt1-IN-3 is a potent membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50s of <10 nM (WO2021195782 A1, compound 95) [1].
    Myt1-IN-3
  • HY-145817

    (Rac)-RP-6306

    Wee1 Cancer
    (Rac)-lunresertib (compound 181) is a potent membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50 of <10 nM. (Rac)-lunresertib (compound 181) has anticancer effects [1].
    (Rac)-lunresertib
  • HY-145817B

    (R)-RP-6306

    Wee1 Cancer
    (R)-lunresertib is a membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor, with IC50 of 1360 nM. (R)-lunresertib can be used in the study of Myt1-mediated cancers [1].
    (R)-lunresertib
  • HY-122113
    PD173952
    1 Publications Verification

    Src Bcr-Abl Apoptosis Wee1 Cancer
    PD173952 is a tyrosine kinases inhibitor with IC50s of 0.3, 1.7 and 6.6 nM against Lyn, Abl and Csk, respectively. PD173952 is also a potent Myt1 kinase inhibitor with a Ki of 8.1 nM. PD173952 induces apoptosis [1] .
    PD173952
  • HY-RS08973

    Small Interfering RNA (siRNA) Others

    MYT1 Human Pre-designed siRNA Set A contains three designed siRNAs for MYT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MYT1 Human Pre-designed siRNA Set A
    MYT1 Human Pre-designed siRNA Set A
  • HY-145665

    Wee1 Cancer
    Myt1-IN-2 is a potent membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50 of <10 nM. Myt1-IN-2 has anticancer effects (WO2021195782A1; compound 28) [1].
    Myt1-IN-2
  • HY-157443

    Wee1 Cancer
    Myt1-IN-4 (21) is an orally active and selective membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor, with an IC50 of 2.6 nM. Myt1-IN-4 (21) possesses antitumor activity [1].
    Myt1-IN-4
  • HY-162988

    Wee1 Cancer
    Myt1-IN-5 (compound 4) is a membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50 of less than 200 nM.
    Myt1-IN-5
  • HY-RS08974

    Small Interfering RNA (siRNA) Others

    MYT1L Human Pre-designed siRNA Set A contains three designed siRNAs for MYT1L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MYT1L Human Pre-designed siRNA Set A
    MYT1L Human Pre-designed siRNA Set A
  • HY-13925
    PD0166285
    Maximum Cited Publications
    6 Publications Verification

    Wee1 Apoptosis Cancer
    PD0166285, a substrate of P-gp, is a WEE1 inhibitor and a weak Myt1 inhibitor with IC50 values of 24 and 72 nM, respectively. PD0166285 exhibits an IC50 of 3.433 μM for Chk1 [1].
    PD0166285
  • HY-13925A

    Wee1 Apoptosis Cancer
    PD0166285 dihydrochloride, a substrate of P-gp, is a WEE1 inhibitor and a weak Myt1 inhibitor with IC50 values of 24 and 72 nM, respectively. PD0166285 dihydrochloride exhibits an IC50 of 3.433 μM for Chk1 [1].
    PD0166285 dihydrochloride

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: